Results 171 to 180 of about 262,681 (286)
Angiotensin II type-1 receptor autoantibodies and effects in neonates of women with preeclampsia. [PDF]
Ponthier L+7 more
europepmc +1 more source
Abstract Aims Renin–angiotensin–aldosterone system inhibitors (RAASi) are foundational in the management of heart failure (HF) and chronic kidney disease (CKD) but increase the risk of hyperkalaemia. To facilitate continuation of RAASi therapy, guidelines suggest managing hyperkalaemia using newer potassium binders such as sodium zirconium ...
Charles V. Pollack Jr.+9 more
wiley +1 more source
Angiotensin-II drives changes in microglia-vascular interactions in rats with heart failure. [PDF]
Althammer F+7 more
europepmc +1 more source
Abstract Aims The last released European guidelines on the management of heart failure (HF) recommend in patients with chronic HF with reduced ejection fraction (HFrEF) a pharmacological approach based on four fundamental drugs to be rapidly implemented and then uptitrated to modify disease progression.
Stefania Paolillo+62 more
wiley +1 more source
Role of agonistic autoantibodies to the angiotensin II type 1 receptor (AT1-AA) in pathogenesis of preeclampsia. [PDF]
Wang J+5 more
europepmc +1 more source
Graphical representation of main findings and article highlights. Abstract Aims Understanding heart failure (HF) characteristics is essential to improve patient outcomes. Categorizing HF beyond left ventricular ejection fraction (LVEF) is challenging due to heterogeneous clinical presentation and aetiologies.
Rubén Fuentes Artiles+4 more
wiley +1 more source
Abstract Background Chronic kidney disease (CKD) has a high prevalence in patients with heart failure (HF) and is associated with prolonged hospitalization, increased need for intensive care and mortality. There is an urgent need to identify factors that influence the interaction between heart and kidney disorders, often described as cardiorenal ...
Alexander Reinecke+7 more
wiley +1 more source
Microinjection of angiotensin II into zebrafish embryos induces transient dilation and elastin disruption of the dorsal aorta. [PDF]
Tanifuji S+6 more
europepmc +1 more source
Mitral valve transcatheter edge‐to‐edge repair in the elderly—A safe and effective therapy
Mitral valve transcatheter edge‐to‐edge repair in elderly patients is safe and offers comparable mitral valve regurgitation reduction and symptom relief to younger patients. At 3 years, increased all‐cause mortality is observed in elderly patients with advanced heart failure and elevated EuroSCORE II.
Dominik Felbel+6 more
wiley +1 more source
Oxidized low-density lipoprotein potentiates angiotensin II-induced Gq activation through the AT1-LOX1 receptor complex. [PDF]
Ihara J+23 more
europepmc +1 more source